Related Experiment Video
Updated: Aug 30, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Cross-reactivity of hypervariable region 1 chimera of hepatitis C virus
Bing-Shui Xiu1, Shi-Gan Ling, Xiao-Guo Song
1Laboratory of Molecular Virology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, P.R.China.
Insights
Researchers analyzed Hepatitis C virus (HCV) hypervariable region 1 (HVR1) sequences from China. They created a chimeric HVR1 protein demonstrating broad cross-reactivity, potentially aiding in vaccine development against the highly variable HCV.
Area of Science:
- Virology
- Immunology
- Protein Engineering
Background:
- The hypervariable region 1 (HVR1) of the Hepatitis C virus (HCV) exhibits significant genetic diversity.
- This high variability poses challenges for developing effective diagnostic tools and vaccines.
- Understanding HVR1 sequence patterns in specific geographic regions, like China, is crucial.
Purpose of the Study:
- To analyze amino acid sequences of HCV HVR1 isolates from China.
- To construct a combinatorial chimeric HVR1 protein with broad, high cross-reactivity.
- To evaluate the potential of this chimera for diagnostic and therapeutic applications.
Main Methods:
- Collection and computational analysis of published Chinese HCV HVR1 sequences.
- Selection and expression of representative HVR1 sequences and mimotopes in E. coli.
- Testing cross-reactivity of purified recombinant HVR1 antigens using ELISA with patient sera.
- Ligation of selected HVR1 sequences to create a combinatorial chimera.
Main Results:
- Twelve representative HVR1 sequences were successfully expressed and purified.
- All purified antigens showed cross-reactivity with a panel of HCV-positive sera.
- A chimeric antigen composed of four complementary HVR1 sequences demonstrated high expression.
- The purified chimera reacted with all tested HCV antibody-positive sera and 90/91 patient sera.
Conclusions:
- The developed chimeric HVR1 antigen exhibits broad and potent cross-reactivity.
- This finding addresses the challenge of HCV's high variability.
- The chimeric antigen shows promise for the development of novel diagnostic assays and vaccines against HCV.
Aim:
To analyze the amino acid sequences of hypervariable region 1 (HVR1) of HCV isolates in China and to construct a combinatorial chimeric HVR1 protein having a very broad high cross-reactivity.
Methods:
All of the published HVR1 sequences from China were collected and processed with a computer program. Several representative HVR1's sequences were formulated based on a consensus profile and homology within certain subdivision. A few reported HVR1 mimotope sequences were also included for a broader representation. All of them were cloned and expressed in E.coli. The cross-reactivity of the purified recombinant HVR1 antigens was tested by ELISA with a panel of sera from HCV infected patients in China. Some of them were further ligated together to form a combinatorial HVR1 chimera.
Results:
Altogether 12 HVR1(s) were selected and expressed in E.coli and purified to homogeneity. All of these purified antigens showed some cross-reactivity with sera in a 27 HCV positive panel. Recombinant HVR1s of No. 1, 2, 4, and 8# showing broad cross-reactivities and complementarity with each other, were selected for the ligation elements. The chimera containing these 4 HVR1s was highly expressed in E.coli. The purified chimeric antigen could react not only with all the HCV antibody positive sera in the panel but also with 90/91 sera of HCV -infected patients.
Conclusion:
The chimeric antigen was shown to have a broad cross-reactivity. It may be helpful for solving the problem caused by high variability of HCV, and in the efforts for a novel vaccine against the virus.
Related Concept Videos
Viral Recombination
Cross-reactivity
Retroviruses
Cytomegalovirus Disease
Hepatitis

